J Med Cases

Journal of Medical Cases, ISSN 1923-4155 print, 1923-4163 online, Open Access

Article copyright, the authors; Journal compilation copyright, J Med Cases and Elmer Press Inc

Journal website http://www.journalmc.org

Case Report

Volume 2, Number 2, April 2011, pages 81-86

A Case of Prostate Carcinoma Discovered With Pulmonary Lymphangitis Carcinomatosa

Figure 2. High resolution computed tomography (HRCT) of the chest in the initial diagnosis. In the lung fields (A), ground glass and granular opacities are present diffusely around bronchovascular bundle. In the macrophotograph of the right middle lobe and part of lower lobe (B), peribronchovascular interstitial thickening (arrows) and interlobular septa thickening which form a polygon (in the circle) are present. In the mediastinal space condition (C), some mediastinal lymph nodes are slightly enlarged.

Figure 7. The prostate biopsy showing a poorly differentiated adenocarcinoma and in which Gleason’s score was 8.

**Table 1.** Blood Examination and Blood Gas Analysis
CBC, complete blood count; WBC, white blood cell; RBC, red blood cell; BBC, blood biochemistry; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; γ-GTP, γ-glutamyltranspeptidase; CPK, creatine phosphate kinase; TP, total protein; UA, uric acid; BUN, blood urea nitrogen; Cre, creatinine; Glu, glucose; HbA_1c, hemoglobin A_1c; CRP, C reactive protein; CEA, carcinoembryonic antigen; sLI-2R, serum interleukin II receptor; PR3, proteinase-3; ANCA, antineutrophil cytoplasmic antibody; MPO, myeloperoxidase; ABG, arterial blood gas analysis; BE, base excess; SaO₂, Oxygen saturation.
CBC		Normal range			Normal Range
WBC	12600/µl	(3900 – 9300)	Cre	0.92 mg/dl
RBC	511 x 10⁴/µl		Na	141 mEq/L
hemoglobin	14.5 g/dl		K	4.0 mEq/L
hematocrit	43.6%		Cl	99 mEq/L	(70 - 109)
platelet	19 x 10⁴/µl		Glu	221 mg/dl	(4.3 - 5.8)
Hemogram			HbA_1c	8.5%	(< 0.3)
neutrophil	76%		CRP	28.4 mg/dl
lymphocyte	16.8%		CEA	0.5 ng/ml
monocyte	6.3%		Ca 19-9	11.1 U/ml	(124 - 466)
eosinophil	0.3%		sIL2R	564 U/ml
basophil	0.6%		KL-6	257 U/ml
BBC			SP-D	17.2 ng/ml
T-Bil	1.9 mg/dl	(0.2 - 1.0)	PR3-ANCA	< 10 EU
AST	95 U/L	(5 - 40)	MPO-ANCA	< 10 EU
ALT	48 U/L	(5 - 45)	ABG
LDH	1293 U/L	(120 - 240)	PH	7.464
γ-GTP	187 U/L	(≤ 85)	PCO₂	31 mm Hg	(32 - 46)
CPK	133 U/L		PO₂	79 mm Hg
TP	6.8 g/dl		HCO₃^-	22.0 mmol/L
UA	4.5 mg/dl		BE	-0.6 mmol/L
BUN	25.9 mg/dl	(8.0 - 20.0)	SaO₂	96.9%

Table 1. Blood Examination and Blood Gas Analysis

CBC, complete blood count; WBC, white blood cell; RBC, red blood cell; BBC, blood biochemistry; AST, aspartate aminotransferase; ALT, alanine aminotransferase; LDH, lactate dehydrogenase; γ-GTP, γ-glutamyltranspeptidase; CPK, creatine phosphate kinase; TP, total protein; UA, uric acid; BUN, blood urea nitrogen; Cre, creatinine; Glu, glucose; HbA_1c, hemoglobin A_1c; CRP, C reactive protein; CEA, carcinoembryonic antigen; sLI-2R, serum interleukin II receptor; PR3, proteinase-3; ANCA, antineutrophil cytoplasmic antibody; MPO, myeloperoxidase; ABG, arterial blood gas analysis; BE, base excess; SaO₂, Oxygen saturation.

CBC

Normal range

Normal Range

WBC

12600/µl

(3900 – 9300)

Cre

0.92 mg/dl

RBC

511 x 10⁴/µl

141 mEq/L

hemoglobin

14.5 g/dl

4.0 mEq/L

hematocrit

43.6%

99 mEq/L

(70 - 109)

platelet

19 x 10⁴/µl

Glu

221 mg/dl

(4.3 - 5.8)

Hemogram

HbA_1c

8.5%

(< 0.3)

neutrophil

76%

CRP

28.4 mg/dl

lymphocyte

16.8%

CEA

0.5 ng/ml

monocyte

6.3%

Ca 19-9

11.1 U/ml

(124 - 466)

eosinophil

0.3%

sIL2R

564 U/ml

basophil

0.6%

KL-6

257 U/ml

BBC

SP-D

17.2 ng/ml

T-Bil

1.9 mg/dl

(0.2 - 1.0)

PR3-ANCA

< 10 EU

AST

95 U/L

(5 - 40)

MPO-ANCA

< 10 EU

ALT

48 U/L

(5 - 45)

ABG

LDH

1293 U/L

(120 - 240)

7.464

γ-GTP

187 U/L

(≤ 85)

PCO₂

31 mm Hg

(32 - 46)

CPK

133 U/L

PO₂

79 mm Hg

6.8 g/dl

HCO₃^-

22.0 mmol/L

4.5 mg/dl

-0.6 mmol/L

BUN

25.9 mg/dl

(8.0 - 20.0)

SaO₂

96.9%